|
|
Physicians
CME Consultants is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Consultants designates this educational activity for a maximum of
1.0 AMA PRA category 1
credit(s)™. Physicians should only claim credit(s) with the extent of their participation of this activity.
|
|
|
|
|
|
Physician Assistants
This program has been reviewed and is approved for a maximum of 1 hour of AAPA Category 1 (Preapproved) CME Credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with the AAPA’s CME Standards for Live Programs and for Commercial support of Live Programs.
|
|
|
|
|
|
Nurses
CME Consultants is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
CME Consultants designates this program for 1.0 contact hours. Participants should claim only those contact hours actually spent in the educational activity. In order to receive credit for this program, each participant must complete the evaluation form and certificate request form.
Certificates will be mailed to program participants in approximately four to six weeks after receipt of the completed evaluation form and certificate request form.
|
|
|
|
|
|
Pharmacists
CME Consultants is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity has been planned and implemented in accordance with the ACPE goals and objectives through the sponsorship of CME Consultants. This activity has been designated for 1 contact hour (0.100 CEU). There will be no fee for this activity. In order to receive credit,
all participants must complete an evaluation, request for credit form and a posttest.
Statements of Credit will be mailed to participants within six weeks.
Series 3 ACPE # 309-000-08-001-L04-P Initial release date January 22, 2008. Planned Expiry
Date: January 22, 2009
Series 4 ACPE # 309-000-08-002-L04-P Initial release date April 03, 2008. Planned Expiry
Date: April 03, 2009
|
|
|
|
|
|
The contents of some CME activities may contain discussions of non-approved or off-label uses of some of the agents mentioned. Please consult the prescribing information for full disclosure of approved uses. In accordance with Policy, presenters have indicated if they have a conflict of interest and if so, it has been resolved.